These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34781756)

  • 1. Impact of Baseline and Postprocedural Intravascular Ultrasound Findings on 1-Year Primary Patency After Drug-Coated Balloon Treatment of Femoropopliteal Lesions.
    Horie K; Tanaka A; Taguri M; Inoue N
    J Endovasc Ther; 2022 Feb; 29(1):66-75. PubMed ID: 34781756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of the Size of Drug-Coated Balloon Therapy on Restenosis Rate in Femoropopliteal Lesions.
    Kurata N; Iida O; Takahara M; Asai M; Masuda M; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Hata Y; Mano T
    J Endovasc Ther; 2023 Apr; 30(2):269-280. PubMed ID: 35249409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Postoperative Lumen Gain on the Reduction of Restenosis Risk after Endovascular Treatment using Drug-coated Balloon for Femoropopliteal Lesions Assessed by Intravascular Ultrasound.
    Horie K; Takahara M; Nakama T; Tanaka A; Tobita K; Hayakawa N; Mori S; Iwata Y; Suzuki K
    J Atheroscler Thromb; 2023 Sep; 30(9):1142-1151. PubMed ID: 36436877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vessel Patency and Associated Factors of Drug-Coated Balloon for Femoropopliteal Lesion.
    Soga Y; Takahara M; Iida O; Tomoi Y; Kawasaki D; Tanaka A; Yamauchi Y; Tobita K; Kozuki A; Fujihara M; Ando K;
    J Am Heart Assoc; 2023 Jan; 12(1):e025677. PubMed ID: 36583431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraluminal vs Subintimal Drug-Coated Balloon Angioplasty for the Treatment of Femoropopliteal Chronic Total Occlusions.
    Toyoshima T; Takahara M; Iida O; Tomoi Y; Kawasaki D; Tanaka A; Yamauchi Y; Tobita K; Kozuki A; Fujihara M; Higuchi Y; Soga Y;
    JACC Cardiovasc Interv; 2024 Mar; 17(5):608-618. PubMed ID: 38479962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
    J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-Year Clinical Outcome and Risk Factor Analysis of Directional Atherectomy Followed With Drug-Coated Balloon for Femoropopliteal Artery Disease.
    Feng Z; Yang S; Sang H; Xue G; Ni Q; Zhang L; Zhang W; Fang X; Ye M
    J Endovasc Ther; 2021 Dec; 28(6):927-937. PubMed ID: 34251279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of IVUS-Derived Vessel Size on Midterm Outcomes After Stent Implantation in Femoropopliteal Lesions.
    Miki K; Fujii K; Tanaka T; Yanaka K; Yoshihara N; Nishimura M; Sumiyoshi A; Horimatsu T; Imanaka T; Fukunaga M; Akahori H; Masuyama T; Ishihara M
    J Endovasc Ther; 2020 Feb; 27(1):77-85. PubMed ID: 31948376
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiographic patterns of restenosis after drug-coated balloon angioplasty for femoropopliteal lesions and 1-year prognosis after repeat endovascular therapy.
    Higashino N; Iida O; Ishihara T; Hata Y; Toyoshima T; Tsukizawa T; Nishian K; Fujihara M; Kawasaki D; Mano T
    Catheter Cardiovasc Interv; 2023 Nov; 102(6):1114-1121. PubMed ID: 37855184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis.
    Mori S; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H
    J Endovasc Ther; 2015 Jun; 22(3):341-9. PubMed ID: 25862363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between physiological assessment and imaging findings during drug-coated balloon treatment for femoropopliteal diseases.
    Iwasaki Y; Shimada T; Sato T; Koike J; Funatsu A; Kobayashi T; Ikeda T; Nakamura S
    Cardiovasc Revasc Med; 2024 Mar; 60():66-71. PubMed ID: 37739885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year clinical outcomes of drug-coated balloon angioplasty and angiographic predictors of restenosis among patients with de novo femoropopliteal lesions.
    Yamaguchi K; Mori S; Fukagawa T; Kishida T; Nakano T; Shirai S; Mizusawa M; Makino K; Honda Y; Tsutsumi M; Kobayashi N; Yamawaki M; Ito Y
    Indian Heart J; 2023; 75(6):403-408. PubMed ID: 37739220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.
    Bausback Y; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
    J Endovasc Ther; 2017 Aug; 24(4):459-467. PubMed ID: 28558502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
    Steiner S; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
    JACC Cardiovasc Interv; 2018 May; 11(10):934-941. PubMed ID: 29730375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry.
    Schmidt A; Piorkowski M; Görner H; Steiner S; Bausback Y; Scheinert S; Banning-Eichenseer U; Staab H; Branzan D; Varcoe RL; Scheinert D
    JACC Cardiovasc Interv; 2016 Apr; 9(7):715-24. PubMed ID: 27056311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Intravascular Ultrasound on Femoropopliteal Artery Endovascular Interventions: A Randomized Controlled Trial.
    Allan RB; Puckridge PJ; Spark JI; Delaney CL
    JACC Cardiovasc Interv; 2022 Mar; 15(5):536-546. PubMed ID: 35272779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of drug-coated balloon versus scaffold device in patients with superficial femoral artery chronic total occlusion.
    Hayakawa N; Kodera S; Arakawa M; Hirano S; Shakya S; Kanda J
    Heart Vessels; 2022 Feb; 37(2):282-290. PubMed ID: 34279711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Intravascular Ultrasound Measurement Values Between Treatment Modalities for Restenosis in Femoropopliteal Lesions.
    Aihara H; Higashitani M; Takimura H; Tobita K; Jujo K; Hozawa K; Yamaguchi T; Iwata Y; Tokuyama H; Sakurai M; Murata N; Fujimoto Y; Kikuchi A; Koganei H; Sato A; Noguchi Y; Ieda M
    Circ J; 2020 Jul; 84(8):1320-1329. PubMed ID: 32581151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of non-flow-limiting spiral dissection after drug-coated balloon angioplasty for de novo femoropopliteal lesions.
    Haraguchi T; Kuramitsu S; Tsujimoto M; Kashima Y; Sato K; Fujita T
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):97-105. PubMed ID: 37975201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.